Beam Therapeutics Inc.
Beam Therapeutics Inc.（BEAM）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · BEAM · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
25
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Beam Therapeutics Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
BEAM 季度内部人买卖趋势
BEAM 内幕交易卖出 · BEAM 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · BEAM CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
BEAM 高管卖出股份 · BEAM 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 1, 2026 | Evans John M. CEO · Director | Sale | 30,078 | $739K | Form 4 |
| Apr 1, 2026 | Simon Amy Chief Medical Officer | Sale | 6,700 | $165K | Form 4 |
| Apr 1, 2026 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale | 3,242 | $80K | Form 4 |
| Apr 1, 2026 | Bellon Christine Chief Legal Officer | Sale | 5,956 | $146K | Form 4 |
| Apr 1, 2026 | Ciaramella Giuseppe President | Sale | 11,810 | $290K | Form 4 |
| Mar 31, 2026 | Bellon Christine Chief Legal Officer | Award | 20,000 | — | Form 4 |
| Mar 31, 2026 | Cavanagh Bethany J SVP, Finance and Treasurer | Award | 20,000 | — | Form 4 |
| Mar 31, 2026 | Simon Amy Chief Medical Officer | Award | 31,750 | — | Form 4 |
| Mar 31, 2026 | Emany Sravan Kumar CFO | Award | 31,750 | — | Form 4 |
| Mar 31, 2026 | Ciaramella Giuseppe President | Award | 40,000 | — | Form 4 |
| Mar 31, 2026 | Evans John M. CEO · Director | Award | 90,000 | — | Form 4 |
| Mar 31, 2026 | Evans John M. CEO · Director | Option | 25,000 | $17K | Form 4 |
| Mar 31, 2026 | Evans John M. CEO · Director | Sale | 25,000 | $569K | Form 4 |
| Mar 30, 2026 | Evans John M. CEO · Director | Sale | 25,000 | $559K | Form 4 |
| Feb 24, 2026 | Ciaramella Giuseppe President | Option | 35,000 | $595K | Form 4 |
| Feb 24, 2026 | Ciaramella Giuseppe President | Sale | 35,000 | $1.12M⚡ | Form 4 |
| Jan 30, 2026 | Evans John M. CEO · Director | Option | 25,000 | $17K | Form 4 |
| Jan 29, 2026 | Evans John M. CEO · Director | Option | 19,336 | $13K | Form 4 |
| Jan 29, 2026 | Evans John M. CEO · Director | Sale | 16,333 | $477K | Form 4 |
| Jan 30, 2026 | Evans John M. CEO · Director | Sale | 22,094 | $625K | Form 4 |
| Jan 30, 2026 | Evans John M. CEO · Director | Sale | 2,906 | $84K | Form 4 |
| Jan 29, 2026 | Evans John M. CEO · Director | Sale | 8,667 | $258K | Form 4 |
| Jan 22, 2026 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale | 6,198 | $217K | Form 4 |
| Jan 22, 2026 | Bellon Christine Chief Legal Officer | Sale | 1,371 | $47K | Form 4 |
| Jan 20, 2026 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale | 3,034 | $91K | Form 4 |
Cavanagh Bethany J
SVP, Finance and Treasurer
日期
Jan 22
股数
6,198
均价
$35.00
总金额
$217K
Cavanagh Bethany J
SVP, Finance and Treasurer
日期
Jan 20
股数
3,034
均价
$30.12
总金额
$91K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 BEAM 内幕交易
BEAM 内幕交易
Beam Therapeutics Inc.（BEAM）内幕交易数据来源于公司内部人（包括Evans John M. (CEO · Director), Bellon Christine (Chief Legal Officer), Simon Amy (Chief Medical Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。BEAM内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Beam Therapeutics Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
BEAM 内幕交易 · 5个问题Beam Therapeutics Inc.（BEAM）的内部人包括高管和董事，如Evans John M. (CEO · Director), Bellon Christine (Chief Legal Officer), Simon Amy (Chief Medical Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026